Powers Advisory Group, LLC Eli Lilly & CO Transaction History

Powers Advisory Group, LLC

$200 Million
Q3 2024

A detailed history of Powers Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Powers Advisory Group, LLC holds 2,367 shares of LLY stock, worth $1.85 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

2,367

Previous 2,296 3.09%

Holding current value

$1.85 Million

Previous $2.08 Million 0.91%

% of portfolio

1.05%

Previous 1.13%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $54,821 - $68,161	71 Added 3.09%	2,367 $2.1 Million
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $5,798 - $7,272	8 Added 0.35%	2,296 $2.08 Million
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $34,347 - $45,952	58 Added 2.6%	2,288 $1.78 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $568,255 - $669,898	-1,082 Reduced 32.67%	2,230 $1.3 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $103,023 - $142,034	-237 Reduced 6.68%	3,312 $1.78 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $1,052 - $1,406	3 Added 0.08%	3,549 $1.66 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $1,553 - $1,824	-5 Reduced 0.14%	3,546 $1.22 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $100,323 - $116,897	-312 Reduced 8.08%	3,551 $0
Q3 2022 Oct 14, 2022	BUY	$296.48 - $337.87 $2,371 - $2,702	8 Added 0.21%	3,863 $1.25 Million
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $39,300 - $46,145	-141 Reduced 3.53%	3,855 $1.25 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $1,173 - $1,458	-5 Reduced 0.12%	3,996 $1.14 Million
Q4 2021 May 06, 2022	BUY	$224.85 - $279.04 $899,624 - $1.12 Million	4,001 New	4,001 $1.11 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Powers Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Powers Advisory Group, LLC with notifications on news.

Account

Powers Advisory Group, LLC Eli Lilly & CO Transaction History